Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997

This publication has 15 references indexed in Scilit:

• Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
  Journal of Clinical Oncology, 2003
• Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia
  British Journal of Haematology, 2001
• Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
  Blood, 2000
• A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia
  Blood, 2000
• A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia
  Blood, 1999
• Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
  New England Journal of Medicine, 1998
• Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.
  Journal of Clinical Oncology, 1997
• A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]
  Blood, 1996
• Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
  New England Journal of Medicine, 1994
• A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972–1991
  European Journal of Haematology, 1993